BioSpace News Archive

Year

• 2005
• 2006
• 2007
• 2008
• 2009
• 2010
• 2011
• 2012
• 2013
• 2014
• 2015
• 2016
• 2017
• 2018
• 2019
• 2020
• 2021
• 2022
• 2023
• 2024
• 2025
• 2026

Month

• January
• February
• March
• April
• May
• June
• July
• August
• September
• October
• November
• December

Day

• 1
• 2
• 4
• 5
• 6
• 7
• 8
• 9
• 10
• 11
• 12
• 13
• 14
• 15
• 17
• 18
• 19
• 20
• 21
• 22
• 24
• 25
• 26
• 27
• 28
• 29
• 30

• Drug Development

  Cynata Therapeutics: Final Preclinical Asthma Study Confirms Efficacy

  The study was conducted under the supervision of Associate Professor Chrishan Samuel and Dr Simon Royce of the Monash Lung Biology Network.

  December 12, 2017

   · 

  6 min read
• Drug Development

  Cynata Release: Final Preclinical Asthma Study Confirms Efficacy

  Cynata Therapeuticsis pleased to announce that it has received the final report on the effects of Cymerus MSCs in combination with or in comparison to the corticosteroid dexamethasone in a further preclinical asthma study.

  December 12, 2017

   · 

  3 min read
• Business

  Stephanie Finnegan Joins Cromos Pharma as Chief Operating Officer, Company Looks to Expand Its North American Footprint

  Ms. Finnegan will join the company’s U.S. office and will oversee its European and US operations.

  December 12, 2017

   · 

  2 min read
• Genetown

  Editas Medicine Reports Data Supporting Multiple Approaches to Create Treatments for Sickle Cell Disease and Beta-Thalassemia

  Experiments support opportunities to develop best-in-class therapies for hemoglobinopathies.

  December 12, 2017

   · 

  3 min read
• GW Pharmaceuticals plc Announces the Closing of Public Offering of ADSs Raising Gross Proceeds of $317.4M and Full Exercise of Underwriter’s Option to Purchase Additional ADSs

  Goldman Sachs & Co. LLC, Morgan Stanley, BofA Merrill Lynch and Cowen acted as joint book-running managers for the offering.

  December 12, 2017

   · 

  5 min read
• Policy

  BioReference Laboratories Supports ACLA Suit Calling to Rescind PAMA Reimbursement Rate

  BioReference Laboratories applauds the ACLA’s decision to advocate for Medicare beneficiaries and laboratories alike by filing suit against the Acting Secretary of the U.S. Department of HHS.

  December 12, 2017

   · 

  2 min read
• Business

  Amgen Announces 15 Percent Increase in 2018 First Quarter Dividend

  Amgen today announced that its Board of Directors declared a $1.32 per share dividend for the first quarter of 2018.

  December 12, 2017

   · 

  5 min read
• Biotech Bay

  LakePharma Raises Growth Capital From Summit Partners and Ampersand Capital Partners

  The funding will be used to enhance LakePharma’s existing service offering and grow the company’s biomanufacturing capabilities.

  December 12, 2017

   · 

  4 min read
• 

  Deals

  NuVasive to Acquire SafePassage for Undisclosed Sum

  With the addition of SafePassage, NCS solidifies its leadership position as the largest provider of outsourced IONM services.

  December 12, 2017

   · 

  5 min read
• Business

  IQVIA and Pierre Fabre Pharmaceuticals Expand Relationship to Deploy IQVIA’s Orchestrated Customer Engagement

  Under the terms of this seven-year agreement, Pierre Fabre Pharmaceuticals will migrate all of its current CRM users to OCE, which Pierre Fabre Pharmaceuticals selected because of its strong “platform of platforms” foundation and open architecture.

  December 12, 2017

   · 

  5 min read